Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kimura, H.
Right arrow Articles by Yamaguchi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimura, H.
Right arrow Articles by Yamaguchi, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 19:222-228 (1989)
© 1989 Foundation for Promotion of Cancer Research

research-article

Cytotoxic Activity of Various LAK Cells against Autologous Lung Cancer, K-562 and Daudi Cells

Hideki Kimura* and Yutaka Yamaguchi

Department of Surgery, Institute of Pulmonary Cancer Research, School of Medicine, Chiba University 1-8-1, Inohana, Chiba 280

*For reprints and all correspondence

Received September 21, 1988; accepted April 19, 1989

Comparative cytotoxic activity and specificity studies of lymphokine activated killer (LAK) cells from different sources and preparations were carried out. Cytotoxic studies of lymphocytes from regional lymph nodes (Rn-LAK), peripheral blood (Pb-LAK) and those stimulated by autologous tumor cells and then activated by recombinant interleukine 2 (St-LAK) against autologous lung cancer cells, were conducted using the 51Cr-releasing test. The cytotoxic activities of these three LAK cells against autologous fibroblasts, allogeneic tumor cells, K-562 and Daudi cells were also compared. A time course experiment disclosed that the cytotoxic activity of Pb-LAK cells against autologous tumor cells reached a maximum on day 3 and declined shortly after the peak while that of Rn-LAK cells gradually increased to a maximum on day 7 and remained at a high titer for at least two weeks. The cytotoxic activity of Rn-LAK cells was significantly higher than that of Pb-LAK cells in seven out of 10 individual experiemnts and that of stimulated LAK (St LAK) cells was higher than the cytotoxic activities of the other LAK cells in eight out of nine experiments. A specificity study showed that Rn-LAK cells possessed a higher cytotoxic activi ty against autologous tumor cells and a lower cytotoxic activity against autologous fibroblasts and allogeneic tumor cells than Pb-LAK cells. A comparative study of cytotoxic activities against K-562, Daudi cells and autologous tumor cells between St- and Rn-LAK cells demonstrated that although there was no difference in natural killer activity, cytotoxic activity against autologous tumor cells as well as the LAK activity of St-LAK cells were higher than that of Rn-LAK cells. These results indicate that the activities and specificities of LAK cells differ according to their source and preparation.

Key Words: Lymphokine activated killer cells • Interleukine 2 • Lung cancer • NK activity • LAK activity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.